The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19

Braude, Philip; Carter, Ben; Short, Roxanna; Vilches-Moraga, Arturo; Verduri, Alessia; Lyndsay Pearce, Miss; Angeline Price, Miss; Quinn, Terence J; Stechman, Michael; Collins, Jemima; Bruce, Eilidh; Einarsson, Alice; Rickard, Frances; Mitchell, Emma; Holloway, Mark; Hesford, James; Barlow-Pay, Fenella; Clini, Enrico; Kyaw Myint, Phyo; Moug, Susan; McCarthy, Kathryn; Hewitt, Jonathan

Citation

Braude , P , Carter , B , Short , R , Vilches-Moraga , A , Verduri , A , Lyndsay Pearce , M , Angeline Price , M , Quinn , T J , Stechman , M , Collins , J , Bruce , E , Einarsson , A , Rickard , F , Mitchell , E , Holloway , M , Hesford , J , Barlow-Pay , F , Clini , E , Kyaw Myint , P , Moug , S , McCarthy , K & Hewitt , J 2020 , ' The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19 ' , IJC Heart & Vasculature , vol. 31 , 100660 . https://doi.org/10.1016/j.ijcha.2020.100660

URI

https://hdl.handle.net/2164/15310

DOI

https://doi.org/10.1016/j.ijcha.2020.100660

Rights

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Collections

All research

AURA - Aberdeen University Research Archive